Background: Recurrent vulvovaginal candidiasis (RVVC) is the second most common cause of genital tract infection in females. Excessive use of fluconazole and other azoles is likely to cause the emergence of the resistant species of Candida. Objective : The purpose of this research was to identify Candida isolates from RVVC and the antifungal effect of fluconazole against them. Methods : In this study, 152 patients with vulvovaginal candidiasis were evaluated for the RVVC form. The Candida isolates were purified using CHROMagar Candida and identified based on the nuclear ribosomal internal transcribed spacer (ITS1-ITS2 rDNA) sequence analysis by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The antifungal susceptibility of C. albicans isolates against fluconazole was determined according to document M27-A3. Results: Out of 152 patients, 20 cases (13.2%) were identified as recurrent form. The frequencies of the Candida species among the patients with RVVC were C. albicans (n = 16, 80%), C. parapsilosis (n = 3, 15%) and C. tropicalis (n = 1, 5%). The most common clinical sign was vaginal discharge (60%). The mean minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of fluconazole against Candida isolates were 32 µg/mL and 64 µg/mL, respectively. Conclusion: C. albicans was the dominant cause of RVVC. The Candida isolates showed relatively high resistance to fluconazole in vitro. Vaginal discharge was the most common clinical sign among patients with RVVC.

No abstract

No abstract

Background: Helicobacter pylori infection is one of the most common chronic bacterial infections in humans, affecting large populations worldwide. Objectives: The aim of this study was to investigate the relationship between H. pylori infection prevalence with ABO and Rh blood groups. Methods: This descriptive-analytical study was conducted with a case-control design on individuals with anti-H. pylori positive test. Patients with IgG pylori were included in the study based on the inclusion criteria. The individuals were divided into two groups based on antibody titer. The case group included subjects with positive serological results with a titer greater than 12 u/mL IgG, and the control group entailed subjects with negative serological results with a titer less than 8 u/mL IgG. The ABO and Rh blood groups of both groups were examined based on case information. Finally, the data were entered into the SPSS software, and a significance level of 5% was considered for all analyses. Results: According to the results of this study, there was no significant relationship between the blood group and H. pylori infection (P > 0.05). However, the prevalence of blood type A was significantly higher in individuals with positive H. pylori IgG test. Conclusions: The current study suggests no association between ABO and Rh groups, but people with A blood group infected with H. pylori need more attention.